Wyatt Investment Research login

 
Forgot password? Not a Subscriber? - Start Here
 
 
HOMEWEEKLY NEWSLETTERMODEL PORTFOLIOSPECIAL REPORTSVIDEO UPDATESCUSTOMER SERVICE
 
 

Tag - Cgs

 

 
Jennifer Schonberger

TeleCommunication Systems, VNUS Medical Technologies and NPS Pharmaceuticals among 52-week highs

TeleCommunication Systems Inc (Nasdaq:TSYS), VNUS Medical Technologies Inc (Nasdaq:VNUS) and NPS Pharmaceuticals Inc (Nasdaq:NPSP) are among the new 52-week highs in Tuesday's trading among companies with market capitalizations under $1 billion.     

Also included among the results: Brooklyn Federal Bancorp Inc (Nasdaq:BFSB), Chyron Corp (Nasdaq:CGS), Transact Technologies Inc (Nasdaq:TACT), Optimer Pharmaceuticals Inc (Nasdaq:OPTR), Farmers Capital Bank Corp (Nasdaq:FFKT) and CombiMatrix Corp (Nasdaq:CBMX).         

Here are the new 52-week highs among small caps:        

[ More » ]
Billy Fisher

Chryon: The whole world is watching

Chyron’s (NYSE:CGS) slogan is “The company the whole world watches” and it couldn’t be more fitting; whether you’re watching ABC, FOX, CBS or ESPN, it is inevitable that you will be watching Chyron’s work as well.

The New York-based company provides broadcast graphics hardware, software and related services to the television industry. In 1970, it introduced its first character generator; today its work is the industry standard.

Its products are used to create 2-D and 3-D titles and moving graphic images for live sports, news and entertainment shows. This includes news titles, sports scores, weather information and finance tickers. The company’s ChyTV business has a full line of products aimed at cashing in on the growing video and digital signage markets. ChyTV video signage products are used at hospitals, universities, and sport and entertainment venues.

The growth that Chyron has experienced over the past few years alone has not gone unnoticed. It was recently included in Fortune Small Business’ list of the 100 fastest-growing companies in the United States, and just last month, Chyron was added to the Russell Microcap Index. The company’s hope is that the move will give its stock more exposure to institutional investors.

Whether or not this expectation materializes, Chyron’s common stock has been doing just fine on its own. It’s up 60% over the past 52 weeks and was trading at $6 per share at Thursday’s close.

Chyron’s first-quarter results reported on May 13, 2008 provided validation for this steep appreciation in stock price. Company management reported a . . .
[ More » ]
Will Atkinson

Gran Tierra Energy, James River Coal and Chyron Corp among 52-week highs

Gran Tierra Energy Inc (AMEX:GTE), James River Coal Co (Nasdaq:JRCC) and Chyron Corp (Nasdaq:CGS) are among the new 52-week highs in Wednesday's trading among companies with market capitalizations under $750 million.

Vision Sciences Inc (AMEX:VSCI), Evolution Petroleum Corp (Nasdaq:EPM) and Gencor Industries Inc (AMEX:GENC) are also among the new 52-week highs.

Here are the new 52-week highs among small caps:
[ More » ]
Jim Oberweis

Oberweis on small caps: Now is the time

Jim Oberweis is president and lead portfolio manager of Oberweis Asset Management and president of The Oberweis Funds. Oberweis Asset Management, Inc. is a growth equity investment management firm that manages approximately $1.5 billion in micro, small, and small/mid capitalization growth strategies globally, primarily for institutional investors and its own proprietary mutual fund family. Oberweis is a Chartered Financial Analyst. He earned an MBA with high honors from the University of Chicago and a B.S. in Computer Science from the University of Illinois. 

SmallCapInvestor.com’s Jennifer Schonberger interviewed Oberweis last week about his outlook for small caps and some of his specific small-cap recommendations.

“Valuations have been pushed down to a point where there are above-average opportunities now with our universe of smaller, high-growth companies. Maybe once a decade you see — for whatever reason — uncertainty and fear in the marketplace push valuations down to a point where even a modest improvement in sentiment for an uncertain economic outlook can dramatically shift the momentum of stock prices. The best example I can give you is 1990, where we saw a similar drop in prices. In 1991, we probably saw the biggest rise ever for smaller growth stocks.

“At some point the valuations are so low that the marginal risk associated with negative news is really not that high. The market already expects everything to be terrible. So if everything is terrible, that’s meeting expectations. If things come out to be not as terrible as people expect, prices will go up. We can tell based on the mathematics of valuations that we’re about as low as we’ve ever been in the last decade. [The recession and the bad news] is completely priced in. Despite horrific results for small growth stocks in the past six or seven months I think they’re very well-positioned going forward on a prospective basis.

“I think (first quarter) earnings will be lousy. They’ll probably remain subdued for the rest of the year. When we get into these types of environments, investors don’t tend to look at the next quarter. They’re discounting the possibility of this continuing on for the next several years. As soon as you see the first rays of . . .

[ More » ]